Presence of reactive microglia and neuroinflammatory mediators in a case of frontotemporal dementia with P301S mutation

Neurodegenerative Diseases

Volumn 8, Issue 4, 2011, Pages 221-229

  Bellucci, Arianna ^a,b,c   Bugiani, Orso ^d   Ghetti, Bernardino ^e   Spillantini, Maria Grazia ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF BRESCIA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d DEPARTMENT OF NEUROSURGERY   (Italy)

^e INDIANA UNIVERSITY   (United States)

Author keywords

Cyclooxygenase 2; Frontotemporal dementia and parkinsonism linked to chromosome 17 with tau mutations; Interleukin 1 ; Microglia; Neuroinflammation

Indexed keywords

CELL SURFACE RECEPTOR; CYCLOOXYGENASE 2; HLA ANTIGEN CLASS 2; INTERLEUKIN 1BETA; TAU PROTEIN;

ADULT; ARTICLE; BRAIN CORTEX; CASE REPORT; CELL ACTIVATION; CELL DIFFERENTIATION; DISEASE COURSE; ENCEPHALITIS; ENZYME ACTIVATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GLIA CELL; HIPPOCAMPUS; HUMAN; IMMUNOHISTOCHEMISTRY; MICROGLIA; NERVE CELL; PHENOTYPE; PRESENILE DEMENTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ADULT; AGE OF ONSET; CYCLOOXYGENASE 2; FRONTOTEMPORAL DEMENTIA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; MICROGLIA; MIDDLE AGED; MUTATION; TAU PROTEINS;

EID: 79955871342     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000322228     Document Type: Article

References (28)

1. Wszolek ZK, Tsuboi Y, Farrer M, Uitti RJ, Hutton ML: Hereditary tauopathies and parkinsonism. Adv Neurol 2003; 91: 153-163.
2. Baba Y, Baker MC, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld AD, Tsuboi Y, Uitti RJ, Farrer MJ, Ghetti B, Hutton ML, Wszolek ZK: Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a P301S tau mutation. J Neural Transm 2007; 114: 947-950. (Pubitemid 47013598)
3. Gasparini L, Terni B, Spillantini MG: Frontotemporal dementia with tau pathology. Neurodegener Dis 2007; 4: 236-253. (Pubitemid 47000416)
4. Bugiani O, Murrell JR, Giaccone G, Hasegawa M, Ghigo G, Tabaton M, Morbin M, Primavera A, Carella F, Solaro C, Grisoli M, Savoiardo M, Spillantini MG, Tagliavini F, Goedert M, Ghetti B: Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999; 58: 667-677. (Pubitemid 29264946)
5. Bugiani O: FTDP-17: phenotypical heterogeneity within P301S. Ann Neurol 2000; 48: 126. (Pubitemid 30432443)
6. Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M: Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 2002; 22: 9340-9351. (Pubitemid 35356177)
7. Bellucci A, Westwood AJ, Ingram E, Casamenti F, Goedert M, Spillantini MG: Induction of inflammatory mediators and microglial activation in mice transgenic for mutant human P301S tau protein. Am J Pathol 2004; 165: 1643-1652. (Pubitemid 39435163)
8. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM: Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007; 53: 337-351. (Pubitemid 46161268)
9. Yoshiyama Y, Kojima A, Ishikawa C, Arai K: Anti-inflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J Alzheimers Dis 2010; 22: 295-306.
10. Wyss-Coray T, Mucke L: Inflammation in neurodegenerative disease -a double-edged sword. Neuron 2002; 35: 419-432. (Pubitemid 34879943)
11. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000; 21: 383-421. (Pubitemid 30349107)
12. Spina S, Farlow MR, Unverzagt FW, Kareken DA, Murrell JR, Fraser G, Epperson F, Crowther RA, Spillantini MG, Goedert M, Ghetti B: The tauopathy associated with mutation +3 in intron 10 of tau: characterization of the MSTD family. Brain 2008; 131: 72-89.
13. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B: Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci USA 1998; 95: 7737-7741. (Pubitemid 28293323)
14. Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995; 189: 167-169.
15. Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E: Sequential phosphorylation of tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 1998; 252: 542-552. (Pubitemid 28156880)
16. Hasegawa M, Jakes R, Crowther RA, Lee VM, Ihara Y, Goedert M: Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett 1996; 384: 25-30. (Pubitemid 26111925)
17. Guillemin GJ, Brew BJ: Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification. J Leukoc Biol 2004; 75: 388-397. (Pubitemid 38316367)
18. Graeber MB, Streit WJ: Microglia: biology and pathology. Acta Neuropathol 2010; 119: 89-105.
19. Rothwell NJ, Luheshi GN: Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-625. (Pubitemid 32007888)
20. Serou MJ, De Coster MA, Bazan NG: Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression. J Neurosci Res 1999; 58: 593-598. (Pubitemid 29530442)
21. Hoozemans JJ, Veerhuis R, Janssen I, Rozemuller AJ, Eikelenboom P: Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E 2 secretion by human neuroblastoma cells: implications for Alzheimer's disease. Exp Gerontol 2001; 36: 559-570. (Pubitemid 32201510)
22. Sheng JG, Zhu SG, Jones RA, Griffin WS, Mrak RE: Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo. Exp Neurol 2000; 163: 388-391. (Pubitemid 30399087)
23. Reynolds CH, Betts JC, Blackstock WP, Nebreda AR, Anderton BH: Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and p38, and glycogen synthase kinase-3beta. J Neurochem 2000; 74: 1587-1595. (Pubitemid 30163980)
24. Pasinetti GM, Aisen PS: Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 1998; 87: 319-324. (Pubitemid 28370892)
25. Hoozemans JJ, Rozemuller AJ, Janssen I, de Groot CJ, Veerhuis R, Eikelenboom P: Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol 2001; 101: 2-8. (Pubitemid 32124493)
26. Hoozemans JJ, van Haastert ES, Veerhuis R, Arendt T, Scheper W, Eikelenboom P, Rozemuller AJ: Maximal COX-2 and ppRb expression in neurons occurs during early Braak stages prior to the maximal activation of astrocytes and microglia in Alzheimer's disease. J Neuroinflammation 2005; 2: 27.
27. Hoozemans JJ, Veerhuis R, Janssen I, van Elk EJ, Rozemuller AJ, Eikelenboom P: The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E 2 secretion by cultured human adult microglia: implications for Alzheimer's disease. Brain Res 2002; 951: 218-226. (Pubitemid 35248018)
28. Minghetti L, Walsh DT, Levi G, Perry VH: In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J Neuropathol Exp Neurol 1999; 58: 1184-1191. (Pubitemid 29519842)